CorMedix Inc.

NasdaqGM:CRMD Stock Report

Market Cap: US$772.9m

CorMedix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:CRMD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 25SellUS$342,600Janet DillioneIndividual30,000US$11.42
23 Oct 25BuyUS$275,500Myron KaplanIndividual25,000US$11.02

Insider Trading Volume

Insider Buying: CRMD insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of CRMD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders5,400,6176.85%
General Public29,744,70337.8%
Institutions43,643,72555.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.8%.


Top Shareholders

Top 25 shareholders own 48.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.22%
BlackRock, Inc.
5,688,303US$55.8m6.13%no data
5.9%
Shaibatalhamd Abdalkader
4,645,630US$45.6m0%no data
5.05%
The Vanguard Group, Inc.
3,977,658US$39.0m-8.04%no data
4.41%
Marshall Wace LLP
3,473,494US$34.1m34.6%0.04%
4.22%
Deerfield Management Company, L.P.
3,323,833US$32.6m0%0.4%
2.33%
State Street Global Advisors, Inc.
1,835,621US$18.0m14.6%no data
2.3%
Geode Capital Management, LLC
1,809,772US$17.8m13.4%no data
2.18%
Citadel Advisors LLC
1,717,087US$16.8m0.17%0.01%
1.6%
Alyeska Investment Group, L.P.
1,262,979US$12.4m68.4%0.04%
1.53%
UBS Asset Management AG
1,207,732US$11.8m159%no data
1%
Oberweis Asset Management, Inc.
785,700US$7.7m62%0.23%
0.98%
Morgan Stanley
775,809US$7.6m13%no data
0.98%
Leap Investments LP
772,900US$7.6m0%0.14%
0.85%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
671,045US$6.6m-53.6%no data
0.84%
Kennedy Capital Management LLC
658,633US$6.5m37.2%0.14%
0.83%
Raymond James Financial, Inc.
651,987US$6.4m647%no data
0.81%
Qube Research & Technologies Ltd
637,497US$6.3m196%0.01%
0.78%
Northern Trust Global Investments
615,605US$6.0m8.53%no data
0.74%
Charles Schwab Investment Management, Inc.
584,482US$5.7m199%no data
0.72%
Palisades Investment Partners, LLC
564,106US$5.5m0.28%2.17%
0.63%
Deep Track Capital, LP
500,000US$4.9m0%0.09%
0.57%
Susquehanna International Group, LLP
448,425US$4.4m136%0.01%
0.56%
Royce & Associates, LP
441,312US$4.3m0%0.04%
0.53%
October Effect Ltd.
420,551US$4.1m36.2%4.75%
0.53%
Invesco Capital Management LLC
420,318US$4.1m176%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/30 13:13
End of Day Share Price 2025/11/28 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CorMedix Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew D'SilvaB. Riley Securities, Inc.
Jason ButlerCitizens JMP Securities, LLC
Jason KolbertD. Boral Capital LLC.